By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

TONIX Pharmaceuticals, Inc. 

509 Madison Ave.
Suite 306
New York  New York  10022  U.S.A.
Phone: 212-980-9155 Fax: 212-923-5700


SEARCH JOBS


Industry
Pharmaceutical

Segment
Pharmaceuticals





Company News
TONIX Pharmaceuticals, Inc. (TNXP) Completes Enrollment In Phase 2 Clinical Trial Of TNX-102 SL In Post-Traumatic Stress Disorder (PTSD) 12/23/2015 10:22:20 AM
TONIX Pharmaceuticals, Inc. (TNXP) Completes Enrollment In Phase II Clinical Study Of TNX-201 In Episodic Tension-Type Headache 12/8/2015 9:24:54 AM
TONIX Pharmaceuticals, Inc. (TNXP) And U.S. Department Of Defense Military Developer In Partnership To Expand Efforts To Examine TNX-102 SL For Post-Traumatic Stress Disorder 12/7/2015 8:07:37 AM
TONIX Pharmaceuticals, Inc. (TNXP) To Participate In Fireside Chat At The Oppenheimer 26th Annual Healthcare Conference 12/1/2015 8:07:57 AM
TONIX Pharmaceuticals, Inc. (TNXP) Presents Additional Data On Tonmya Demonstrating Improvements In Sleep, Pain, And Other Outcomes In Fibromyalgia At 2015 American College of Rheumatology/ARHP Annual Meeting 11/10/2015 10:59:21 AM
TONIX Pharmaceuticals, Inc. (TNXP) Reports Third Quarter 2015 Financial Results And Provides Programs Update 11/9/2015 8:40:16 AM
TONIX Pharmaceuticals, Inc. (TNXP) Announces Acceptance Of Three Abstracts To Be Presented At The 2015 ACR/ARHP Annual Meeting 10/1/2015 10:19:11 AM
TONIX Pharmaceuticals, Inc. (TNXP) To Present At The 15th Annual Biotech In Europe Forum For Global Partnering And Investment 9/24/2015 12:46:49 PM
TONIX Pharmaceuticals, Inc. (TNXP) To Present At The Rodman & Renshaw Global Investment Conference 9/8/2015 2:46:43 PM
TONIX Pharmaceuticals, Inc. (TNXP) Presents On The Development Of TNX-102 SL For Post-Traumatic Stress Disorder (PTSD) At The 2015 Military Health System Research Symposium 8/19/2015 7:47:33 AM
12345678910
//-->